Ivan Bieche Selected Research

Inflammatory Breast Neoplasms

10/2013	miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness.
2/2008	NF-kappa B genes have a major role in inflammatory breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivan Bieche Research Topics

Disease

75	Neoplasms (Cancer) 10/2023 - 07/2004
36	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2002
11	Carcinogenesis 10/2020 - 04/2003
10	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 04/2003
8	Carcinoma (Carcinomatosis) 01/2020 - 04/2003
7	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2007
5	Triple Negative Breast Neoplasms 10/2023 - 01/2014
5	Adenocarcinoma 11/2021 - 10/2008
5	Squamous Cell Carcinoma of Head and Neck 01/2020 - 07/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 09/2011
4	Non-Muscle Invasive Bladder Neoplasms 10/2019 - 06/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 10/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2017
3	Inflammation (Inflammations) 01/2018 - 02/2008
3	Melanoma (Melanoma, Malignant) 01/2017 - 09/2007
3	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 06/2015 - 01/2010
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 09/2023
2	Lung Neoplasms (Lung Cancer) 02/2023 - 01/2023
2	Disease Progression 02/2023 - 08/2012
2	Microsatellite Instability 02/2023 - 12/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 06/2015
2	Alcoholic Fatty Liver 01/2021 - 05/2011
2	Liver Diseases (Liver Disease) 01/2021 - 07/2019
2	Retinal Degeneration 10/2020 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 07/2019 - 03/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 03/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2015 - 07/2008
2	Glioblastoma (Glioblastoma Multiforme) 03/2014 - 02/2013
2	Inflammatory Breast Neoplasms 10/2013 - 02/2008
2	Meningioma (Meningiomas) 07/2010 - 07/2009

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2011
20	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
20	Proteins (Proteins, Gene)FDA Link 04/2021 - 09/2002
10	Estrogen ReceptorsIBA 01/2018 - 07/2004
9	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 04/2011
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2014 - 10/2004
6	Tamoxifen FDA LinkGeneric 02/2012 - 01/2008
6	Estrogen Receptor alphaIBA 02/2009 - 07/2004
5	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2014
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2009
4	ParaffinIBA 01/2020 - 01/2017
4	Formaldehyde (Formol)FDA Link 01/2020 - 01/2017
4	Protein Isoforms (Isoforms)IBA 07/2019 - 07/2004
4	Circulating Tumor DNAIBA 03/2019 - 04/2015
4	EnzymesIBA 01/2019 - 04/2003
4	MicroRNAs (MicroRNA)IBA 07/2015 - 06/2013
3	Bevacizumab (Avastin)FDA Link 11/2023 - 03/2014
3	NivolumabIBA 01/2023 - 11/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 07/2019
3	RNA (Ribonucleic Acid)IBA 09/2020 - 07/2016
3	CytokinesIBA 01/2020 - 09/2005
3	ChemokinesIBA 01/2020 - 09/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2018
3	LigandsIBA 01/2018 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 01/2008
3	Cerebroside-Sulfatase (Arylsulfatase A)IBA 06/2015 - 01/2010
3	Estrogens (Estrogen)FDA Link 03/2008 - 07/2004
2	Hormones (Hormone)IBA 01/2024 - 07/2015
2	exemestane (Aromasin)FDA Link 01/2024 - 07/2007
2	TOR Serine-Threonine KinasesIBA 01/2024 - 10/2008
2	Everolimus FDA Link 01/2024 - 06/2016
2	Cell-Free Nucleic AcidsIBA 12/2022 - 03/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	durvalumabIBA 01/2022 - 01/2021
2	pembrolizumabIBA 11/2021 - 11/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2015
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 12/2013
2	B7-H1 AntigenIBA 01/2021 - 01/2017
2	InterferonsIBA 10/2020 - 10/2010
2	TubulinIBA 10/2020 - 01/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 06/2015
2	PlatinumIBA 11/2019 - 09/2011
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2019 - 01/2016
2	Trastuzumab (Herceptin)FDA Link 11/2018 - 11/2005
2	human ERBB2 proteinIBA 01/2018 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 04/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 10/2015
2	Carboplatin (JM8)FDA LinkGeneric 09/2016 - 07/2008
2	Sunitinib (Sutent)FDA Link 06/2016 - 05/2011
2	Sorafenib (BAY 43-9006)FDA Link 06/2016 - 05/2011
2	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 09/2014 - 09/2011
2	Transcription Factors (Transcription Factor)IBA 02/2013 - 07/2010
2	Sulfoglycosphingolipids (Sulfatides)IBA 08/2012 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 03/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2011 - 07/2008
2	VimentinIBA 05/2011 - 05/2010
2	Cadherins (E-Cadherin)IBA 05/2011 - 05/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2011 - 03/2010
2	Protein Kinase CIBA 05/2010 - 05/2009

Therapy/Procedure

29	Therapeutics 01/2024 - 12/2005
11	Drug Therapy (Chemotherapy) 10/2023 - 03/2008
8	Immunotherapy 10/2023 - 01/2017
4	Precision Medicine 01/2022 - 04/2011
3	Chemoradiotherapy 01/2023 - 06/2015
3	Radiotherapy 01/2021 - 09/2016
2	Cystectomy 10/2019 - 01/2017